Global Opioid Induced Constipation Market Research Report 2021
- Published Date: 2021-02-20
- Report ID: 57936
- Pages: 110
-
Format:
Prudent Markets Predicts that Opioid Induced Constipation Market was valued USD xxxx unit in 2020 and is expected to reach USD xxxx Unit by the year 2025, growing at a CAGR of xx% globally.
Global Opioid Induced Constipation Market Overview:
Global Opioid Induced Constipation Market Report 2020 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2020-2025.This research study of Opioid Induced Constipation involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Impact of COVID-19 on Opioid Induced Constipation Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affected the Opioid Induced Constipation market in 2020.
Global Opioid Induced Constipation Market Segmentation
By Type, Opioid Induced Constipation market has been segmented into:
Methylnaltrexone Bromide
Lubiprostone
Naloxegol
By Application, Opioid Induced Constipation market has been segmented into:
Hospital
Pharmacy
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Top Key Players Covered in Opioid Induced Constipation market are:
Takeda Pharmaceuticals
Bayer
Mallinckrodt
Salix (Bausch Health)
AstraZeneca
Progenics Pharmaceuticals
Purdue Pharm
Nektar Therapeutics
Daiichi Sankyo
Sanofi
Prestige
GSK
Shionogi
1. Market Overview of Opioid Induced Constipation
1.1 Opioid Induced Constipation Market Overview
1.1.1 Opioid Induced Constipation Product Scope
1.1.2 Market Status and Outlook
1.2 Opioid Induced Constipation Market Size by Regions: 2015 VS 2021 VS 2026
1.3 Opioid Induced Constipation Historic Market Size by Regions (2015-2020)
1.4 Opioid Induced Constipation Forecasted Market Size by Regions (2021-2026)
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Opioid Induced Constipation Sales Market by Type (2015-2026)
2.1 Global Opioid Induced Constipation Historic Market Size by Type (2015-2020)
2.2 Global Opioid Induced Constipation Forecasted Market Size by Type (2021-2026)
2.3 Methylnaltrexone Bromide
2.4 Lubiprostone
2.5 Naloxegol
3. Covid-19 Impact Opioid Induced Constipation Sales Market by Application (2015-2026)
3.1 Global Opioid Induced Constipation Historic Market Size by Application (2015-2020)
3.2 Global Opioid Induced Constipation Forecasted Market Size by Application (2021-2026)
3.3 Hospital
3.4 Pharmacy
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Opioid Induced Constipation Production Capacity Market Share by Manufacturers (2015-2020)
4.2 Global Opioid Induced Constipation Revenue Market Share by Manufacturers (2015-2020)
4.3 Global Opioid Induced Constipation Average Price by Manufacturers (2015-2020)
5. Company Profiles and Key Figures in Opioid Induced Constipation Business
5.1 Takeda Pharmaceuticals
5.1.1 Takeda Pharmaceuticals Company Profile
5.1.2 Takeda Pharmaceuticals Opioid Induced Constipation Product Specification
5.1.3 Takeda Pharmaceuticals Opioid Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.2 Bayer
5.2.1 Bayer Company Profile
5.2.2 Bayer Opioid Induced Constipation Product Specification
5.2.3 Bayer Opioid Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.3 Mallinckrodt
5.3.1 Mallinckrodt Company Profile
5.3.2 Mallinckrodt Opioid Induced Constipation Product Specification
5.3.3 Mallinckrodt Opioid Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.4 Salix (Bausch Health)
5.4.1 Salix (Bausch Health) Company Profile
5.4.2 Salix (Bausch Health) Opioid Induced Constipation Product Specification
5.4.3 Salix (Bausch Health) Opioid Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.5 AstraZeneca
5.5.1 AstraZeneca Company Profile
5.5.2 AstraZeneca Opioid Induced Constipation Product Specification
5.5.3 AstraZeneca Opioid Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.6 Progenics Pharmaceuticals
5.6.1 Progenics Pharmaceuticals Company Profile
5.6.2 Progenics Pharmaceuticals Opioid Induced Constipation Product Specification
5.6.3 Progenics Pharmaceuticals Opioid Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.7 Purdue Pharm
5.7.1 Purdue Pharm Company Profile
5.7.2 Purdue Pharm Opioid Induced Constipation Product Specification
5.7.3 Purdue Pharm Opioid Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.8 Nektar Therapeutics
5.8.1 Nektar Therapeutics Company Profile
5.8.2 Nektar Therapeutics Opioid Induced Constipation Product Specification
5.8.3 Nektar Therapeutics Opioid Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.9 Daiichi Sankyo
5.9.1 Daiichi Sankyo Company Profile
5.9.2 Daiichi Sankyo Opioid Induced Constipation Product Specification
5.9.3 Daiichi Sankyo Opioid Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.10 Sanofi
5.10.1 Sanofi Company Profile
5.10.2 Sanofi Opioid Induced Constipation Product Specification
5.10.3 Sanofi Opioid Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.11 Prestige
5.11.1 Prestige Company Profile
5.11.2 Prestige Opioid Induced Constipation Product Specification
5.11.3 Prestige Opioid Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.12 GSK
5.12.1 GSK Company Profile
5.12.2 GSK Opioid Induced Constipation Product Specification
5.12.3 GSK Opioid Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.13 Shionogi
5.13.1 Shionogi Company Profile
5.13.2 Shionogi Opioid Induced Constipation Product Specification
5.13.3 Shionogi Opioid Induced Constipation Production Capacity, Revenue, Price and Gross Margin (2015-2020)
6. North America
6.1 North America Opioid Induced Constipation Market Size (2015-2026)
6.2 North America Opioid Induced Constipation Key Players in North America (2015-2020)
6.3 North America Opioid Induced Constipation Market Size by Type (2015-2020)
6.4 North America Opioid Induced Constipation Market Size by Application (2015-2020)
7. East Asia
7.1 East Asia Opioid Induced Constipation Market Size (2015-2026)
7.2 East Asia Opioid Induced Constipation Key Players in North America (2015-2020)
7.3 East Asia Opioid Induced Constipation Market Size by Type (2015-2020)
7.4 East Asia Opioid Induced Constipation Market Size by Application (2015-2020)
8. Europe
8.1 Europe Opioid Induced Constipation Market Size (2015-2026)
8.2 Europe Opioid Induced Constipation Key Players in North America (2015-2020)
8.3 Europe Opioid Induced Constipation Market Size by Type (2015-2020)
8.4 Europe Opioid Induced Constipation Market Size by Application (2015-2020)
9. South Asia
9.1 South Asia Opioid Induced Constipation Market Size (2015-2026)
9.2 South Asia Opioid Induced Constipation Key Players in North America (2015-2020)
9.3 South Asia Opioid Induced Constipation Market Size by Type (2015-2020)
9.4 South Asia Opioid Induced Constipation Market Size by Application (2015-2020)
10. Southeast Asia
10.1 Southeast Asia Opioid Induced Constipation Market Size (2015-2026)
10.2 Southeast Asia Opioid Induced Constipation Key Players in North America (2015-2020)
10.3 Southeast Asia Opioid Induced Constipation Market Size by Type (2015-2020)
10.4 Southeast Asia Opioid Induced Constipation Market Size by Application (2015-2020)
11. Middle East
11.1 Middle East Opioid Induced Constipation Market Size (2015-2026)
11.2 Middle East Opioid Induced Constipation Key Players in North America (2015-2020)
11.3 Middle East Opioid Induced Constipation Market Size by Type (2015-2020)
11.4 Middle East Opioid Induced Constipation Market Size by Application (2015-2020)
12. Africa
12.1 Africa Opioid Induced Constipation Market Size (2015-2026)
12.2 Africa Opioid Induced Constipation Key Players in North America (2015-2020)
12.3 Africa Opioid Induced Constipation Market Size by Type (2015-2020)
12.4 Africa Opioid Induced Constipation Market Size by Application (2015-2020)
13. Oceania
13.1 Oceania Opioid Induced Constipation Market Size (2015-2026)
13.2 Oceania Opioid Induced Constipation Key Players in North America (2015-2020)
13.3 Oceania Opioid Induced Constipation Market Size by Type (2015-2020)
13.4 Oceania Opioid Induced Constipation Market Size by Application (2015-2020)
14. South America
14.1 South America Opioid Induced Constipation Market Size (2015-2026)
14.2 South America Opioid Induced Constipation Key Players in North America (2015-2020)
14.3 South America Opioid Induced Constipation Market Size by Type (2015-2020)
14.4 South America Opioid Induced Constipation Market Size by Application (2015-2020)
15. Rest of the World
15.1 Rest of the World Opioid Induced Constipation Market Size (2015-2026)
15.2 Rest of the World Opioid Induced Constipation Key Players in North America (2015-2020)
15.3 Rest of the World Opioid Induced Constipation Market Size by Type (2015-2020)
15.4 Rest of the World Opioid Induced Constipation Market Size by Application (2015-2020)
16 Opioid Induced Constipation Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porters Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
